Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 217M | $14.9M | $0.07 | Mar 29, 2024 | Direct |
ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 2.7M | $186K | $0.07 | Mar 29, 2024 | by IRA |
ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 2.22M | $153K | $0.07 | Mar 29, 2024 | by Kristine Hakim |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELTP | ELITE PHARMACEUTICALS INC /NV/ | Mar 29, 2024 | 1 | $0 | 4 | Apr 2, 2024 | CEO, President, Director, 10%+ Owner |
ELTP | ELITE PHARMACEUTICALS INC /NV/ | Dec 29, 2023 | 0 | $0 | 4/A | Apr 2, 2024 | CEO & President, Director, 10%+ Owner |
ELTP | ELITE PHARMACEUTICALS INC /NV/ | Dec 29, 2023 | 1 | $153K | 4 | Dec 29, 2023 | CEO, President, Director, 10%+ Owner |